Tech Company Financing Transactions

Eloxx Pharma Funding Round

On 8/3/2017, Eloxx Pharma received $8 million in Series C funding from LSP BioVentures, Catalyst Capital Managment and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

950 Winter St.
Waltham, MA 02451
USA

Phone

(781) 577-5300

Website

www.eloxxpharma.com

Email Address

[email protected]

Overview

Eloxx Pharmaceuticals is a clinical stage company developing first in class therapeutics for the treatment of genetic disease caused by non-sense mutations.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Bob Ward

        

Chief Financial Officer

Gregory Weaver

        

Chief Operating Officer

Gregory Williams

        

Founder

Silvia Noiman

        

VP - Bus. Development

David Snow

        

Browse more venture capital transactions:

Prev: 8/3/2017: Rodeo Therapeutics venture capital transaction
Next: 8/3/2017: Gimlet Media venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We record every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary